Nevertheless, our findings demonstrate that Pontin is a vital cell cycle regulator at least by amplifying E2F1 transcription response in glioma, shedding light on the possibility of targeting Pontin for anti-glioma therapy. Here, RUVBL1 is linked to glioma.